APA (7th ed.) Citation

Yutkin, V., Maalouf, N., Gur, C., Zini, A., Bachrach, G., & Mandelboim, O. (2026). Targeting Bladder Cancer with Inactivated Uropathogenic E. coli: A Novel Alternative to BCG Immunotherapy. Cells (2073-4409), 15(3), 229. https://doi.org/10.3390/cells15030229

Chicago Style (17th ed.) Citation

Yutkin, Vladimir, Naseem Maalouf, Chamutal Gur, Avraham Zini, Gilad Bachrach, and Ofer Mandelboim. "Targeting Bladder Cancer with Inactivated Uropathogenic E. Coli: A Novel Alternative to BCG Immunotherapy." Cells (2073-4409) 15, no. 3 (2026): 229. https://doi.org/10.3390/cells15030229.

MLA (9th ed.) Citation

Yutkin, Vladimir, et al. "Targeting Bladder Cancer with Inactivated Uropathogenic E. Coli: A Novel Alternative to BCG Immunotherapy." Cells (2073-4409), vol. 15, no. 3, 2026, p. 229, https://doi.org/10.3390/cells15030229.